Parikh, M., Pan, C., Beckett, L. A., Li, Y., Robles, D. A., Aujla, P. K., & Lara, P. N. (2018). Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study. Clin Genitourin Cancer.

Parikh, Mamta, Chong-Xian Pan, Laurel A. Beckett, Yueju Li, Daniel A. Robles, Pawandeep K. Aujla, and Primo N. Lara. "Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study." Clin Genitourin Cancer 2018.

Parikh, Mamta, et al. "Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study." Clin Genitourin Cancer 2018.